Thought Leadership
When it comes to thought leadership and staying informed, we’ve got you covered. See below for recent articles, webinars, and downloadable resources available.
Want updates like these sent directly to your inbox?
Over the past year, there have been many changes within the 340B Program. Join Jason Prokopik from Blue & Co., LLC and Wes Butler from Barnett Benvenuti & Butler on Tuesday, February 9 from noon to 1 p.m. EST as they discuss how the recent political changes could impact the 340B Program and what it […]
On December 27, 2020, President Trump signed into law the Consolidated Appropriations Act (CAA), 2021. Included in this bill are comprehensive Rural Health Clinic reimbursement changes and provide possible new opportunities for both RHCs and hospitals. Rural Health Clinic Medicare Rates The most significant change included in the CAA was made to the RHC Medicare rates. […]
Blue & Co., LLC is excited to announce it has recently expanded its pharmacy and 340B expertise to meet and exceed the needs of its clients. With the addition of multiple pharmacy staff members in 2020, Blue is positioned to provide a wide array of pharmacy consulting services to healthcare organizations looking for guidance. About […]
The 2021 Grantee 340B Recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung Programs, Urban Indian, and Tribal Compact 638 will be February 1 – March 1, 2021. A separate email will be sent out by HRSA with all of the information required […]
With current attacks on the 340B Program by some pharmaceutical manufacturers and other challenges affecting patients in need of prescription drugs, is it time for your Hospital or Health Center to consider a retail pharmacy strategy of its own? Some Hospitals and Health Centers own retail pharmacies, but opportunity still exists to improve the patient […]
340B covered entities have likely felt bombarded during the last few weeks with various letters from manufacturers, word of additional cuts in Medicare part B drug reimbursement for some hospitals, and an executive order about insulin and epi-pens for community health centers. Advocacy groups, including 340B Health, the National Association of Chain Drugstores, the American […]
AstraZeneca distributed letters recently that as of October 1, 2020, 340B pricing will be available only through “a single contract pharmacy for those covered entities that do not maintain their own on-site dispensing pharmacies.” Eli Lilly had previously stated it would provide Cialis at 340B pricing to only one contract pharmacy location for each entity. […]
In 2018, the Center for Medicare & Medicaid Services (CMS) implemented a change in reimbursement for DSHs, RRCs, and non-rural SCHs for Medicare Part B drugs obtained through the 340B Program, adjusting reimbursement amounts based on a value of Average Sales Price (ASP) – 22.5% from the previous value of ASP + 6%. This was […]
The Health Resources and Services Administration has set the annual recertification of eligibility for 340B drug discounts for hospitals to begin August 17, 2020 and end September 14, 2020. Mandatory Requirement Hospitals must complete their recertification through the Office of Pharmacy Affairs Information System (OPAIS). The Authorizing Official and Primary Contact must create their own […]
Merck & Co. is communicating directly with covered entities asking for contract pharmacy claim data to be submitted to Merck via a secure web portal. Merck states the data will be used “to match against rebate claims it receives to ensure it isn’t paying duplicate Medicaid discounts and duplicate discounts on Medicare Part D and […]
HRSA has indicated it will allow a hospital to accelerate timelines for its offsite locations to begin participating in the 340B Drug Discount Program. Previously, offsite locations were required to be reimbursable on a hospital’s most recently filed Medicare cost report and then registered with HRSA before patients seen at the offsite location could be […]
The White House Office of Management and Budget (OMB) approved the Centers for Medicare & Medicaid Services’ (CMS) plan, proposed September 30, 2019, to survey 340B hospitals for their net costs for 340B-purchased drugs billed to Medicare Part B, including sub-340B ceiling price discounts and 340B penny prices. CMS announced the final survey requirement on […]
This article was originally published on March 25th and was updated on April 23rd. It is being updated as new information becomes available. We wanted to provide updates on the most recent HRSA announcements that could impact your 340B Program during the COVID-19 crisis. 340B Eligibility HRSA recently announced that it “is allowing some entities, […]
We wanted to share an urgent update on the impending billing changes that were scheduled to take effect on 4/1/2020. In a communication we acquired today from Jessin Joseph, Pharmacy Director with KY Department of Medicaid Services, it was announced the Department has made the decision to delay the implementation of the required 340B modifiers […]
Consolidated Health Center & FQHC Look-a-Likes The 2020 Grantee recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung Programs, Urban Indian, and Tribal Compact 638 will be January 27-February 24, 2020. Mandatory Requirement Health clinics must complete their recertifications through the Office of […]
Webinars
Over the past year, there have been many changes within the 340B Program. Join Jason Prokopik from Blue & Co., LLC and Wes Butler from Barnett Benvenuti & Butler on Tuesday, February 9 from noon to 1 p.m. EST as they discuss how the recent political changes could impact the 340B Program and what it […]
On December 27, 2020, President Trump signed into law the Consolidated Appropriations Act (CAA), 2021. Included in this bill are comprehensive Rural Health Clinic reimbursement changes and provide possible new opportunities for both RHCs and hospitals. Rural Health Clinic Medicare Rates The most significant change included in the CAA was made to the RHC Medicare rates. […]
Blue & Co., LLC is excited to announce it has recently expanded its pharmacy and 340B expertise to meet and exceed the needs of its clients. With the addition of multiple pharmacy staff members in 2020, Blue is positioned to provide a wide array of pharmacy consulting services to healthcare organizations looking for guidance. About […]
The 2021 Grantee 340B Recertification period for Consolidated Health Centers, Federal Qualified Health Center Look-Alikes, Ryan White, Comprehensive Hemophilia Treatment Centers, Native Hawaiian, Black Lung Programs, Urban Indian, and Tribal Compact 638 will be February 1 – March 1, 2021. A separate email will be sent out by HRSA with all of the information required […]
With current attacks on the 340B Program by some pharmaceutical manufacturers and other challenges affecting patients in need of prescription drugs, is it time for your Hospital or Health Center to consider a retail pharmacy strategy of its own? Some Hospitals and Health Centers own retail pharmacies, but opportunity still exists to improve the patient […]
340B covered entities have likely felt bombarded during the last few weeks with various letters from manufacturers, word of additional cuts in Medicare part B drug reimbursement for some hospitals, and an executive order about insulin and epi-pens for community health centers. Advocacy groups, including 340B Health, the National Association of Chain Drugstores, the American […]